SLC2A3 and cancer: Pan-cancer single-cell RNA-seq data revealed that GLUT1 is highly expressed in cancer cells, while GLUT3 exhibits elevated expression in immune cells, indicating distinct regulatory mechanisms governing glucose transporter families in cancer and immune cells, with RNA modifications potentially serving as a regulatory factor [280].